Human Medicines European Public Assessment Report (EPAR): Cervarix, Human Papillomavirus Vaccine [Types 16, 18] (Recombinant, Adjuvanted, Adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Immunization, Date of Authorisation: 20/09/2007, Revision: 32, Status: Authorised

Case Medical Research

doi 10.31525/cmr-145d596